RecruitingNCT06761144

Pulmonary Thromboembolism in Cancer Patients: Early Rule-out From the Emergency Department


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

500 participants

Start Date

Jul 13, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Pulmonary thromboembolism is a frequent complication of cancer; in some cases, it is diagnosed occasionally during diagnostic examinations as part of the regular follow-up of the disease. Not all patients diagnosed with thromboembolism present symptoms; therefore, after appropriate investigations during observation in the emergency room and/or a short hospitalisation in Emergency Medicine, they could be discharged home, avoiding lengthy hospitalisations that would have a considerable impact on their health and psychological condition. The goal of this observational study is to compare the efficacy of several assessment scales for use by physicians to identify patients at low risk of developing serious complications of pulmonary embolism within 30 days of diagnosis, in order to be able to identify a group of low-risk patients who could be discharged early from the emergency department/emergency medicine safely. What does participation in this study entail compared to the normal care you receive and what are your responsibilities as a participant? At the time of patient enrolment in the emergency room/emergency medicine, the data necessary for the calculation of 6 scoring systems will be collected, which will take approximately 5 minutes. The patient enrolled in the study will be contacted by telephone in order to assess the state of health; the call will take approximately 1 minute and will take place 30 days after access to the emergency room. Participation in the study does not entail any obligation or restriction, nor will it be charged for.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether cancer patients who develop a blood clot in the lungs (called pulmonary embolism or PE) can be safely sent home from the emergency department instead of being hospitalized. This is a care pathway study, not a new drug trial. **You may be eligible if...** - You are 18 or older - You have an active blood cancer or solid tumor being treated by an oncologist - You have been diagnosed with a pulmonary embolism (either with symptoms or found incidentally) - You agree to participate **You may NOT be eligible if...** - You are returning to the ER for complications from a previously diagnosed pulmonary embolism Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Eleonora Tubertini

Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06761144


Related Trials